Mahiuddin Ahmed, Ph.D.
Dr. Ahmed is the President and CSO of VITRUVIAE, a privately held biotechnology company developing pan-agents for cancer, infectious diseases, and mental illness. He was formerly the SVP and CSO of Y-mAbs Therapeutics, a commercial and clinical stage public biotechnology company, and a faculty member in the Department of Pediatrics at Memorial Sloan Kettering Cancer …